Now in its 21st year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The 21st Annual Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.
* Date of Original Date: Thursday, July 25, 2024
LEARNING OBJECTIVES
At the conclusion of this activity, the participant will be able to:
- Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
- Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
- Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
- Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
- Understand the evidence for vitamin D in the optimization of bone health;
- Recognize racial differences and disparities in osteoporosis care.
THE 21ST ANNUAL OSTEOPOROSIS: NEW INSIGHTS IN RESERCH, DIAGNOSIS, AND CLINICAL CARE
